「the 20」の検索結果
144件：71～75件目を表示
-
. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of software for dry-eye analysis in Japan as an option of RET-700, effect...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf -
. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of RET-700 in Japan, effective immediately (medical device approval numbe...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
Animal Science | Business Activities | About Senju | SENJU Pharmaceutical
s-Enhancing Enterprise with a Consummate Pet-related Product Line Pets are our precious companions. They have the right to enjoy the same comforts we do. Through the development of animal pharmaceutic...
https://www.senju.co.jp/english/about/business/animal.html -
. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of RET-700 in Japan, effective immediately (medical device approval numbe...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
o-Controlled Phase 3 Pivotal Study – Yuichi Hori, MD, PhD; Tomoyuki Wada, PhD; Kazunori Omatsu, BSc the 59th Congress of the European Societies of Toxicology 開催日：2025年9月14日～2025年9月17日 開催地：Athens, GREE...
https://www.senju.co.jp/english/rd/society/